Diltiazem retards the metabolism of oral prednisone with effects on T- cell markers

Pediatric Transplantation

Volumn 3, Issue 2, 1999, Pages 126-130

  Imani, S ^a   Jusko, W J ^b   Steiner, Robert W ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

Diltiazem; Immunesuppression; Prednisone; Transplant

Indexed keywords

BETAMETHASONE; CD3 ANTIGEN; CD8 ANTIGEN; CYTOCHROME P450; DILTIAZEM; HYDROCORTISONE; LYMPHOCYTE SURFACE MARKER; PREDNISOLONE; PREDNISONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; LYMPHOCYTE COUNT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0033021738     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3046.1999.00027.x     Document Type: Article

References (23)

1. FREY FJ. Pharmacokinetic determinants of cyclosporine and prednisone in renal transplant patients. Kidney Int 1991: 39: 1034-1050.
2. KAHAN BD. Calcium channel blockers: what do we know of their effects on cyclosporine A-treated transplant recipients? Transplant Immunol Lett 1994: 10: 2.
3. BUCKLEY MMT, GRANT SM, GOA KL, MCTANISH D, SORKIN EM. Diltiazem: a reappraisal of its pharmacological properties and therapeutic use. Drugs 1990: 39: 757-806.
4. JUSKO WJ, LUDWIG EA. Corticosteroids., In: EVANS WE, SCHENTAG JJ, JUSKO WJ, eds. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, 3rd edn. Vancouver, WA: Applied Therapeutics Inc, 1992, 27-1-27-34.
5. JUSKO WJ, PYSZCZYNSKI NA, BUSHWAY MD, D'AMBROSIO R, MIS SM. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J Chromatogr B 1994: 658: 47-54.
6. ROCCI ML, JUSKO WJ. LAGRAN program for area and moments in pharmacokinetic and analysis. Computer Programs Biomed 1983: 16: 203-216.
7. WALD JA, JUSKO WJ, LAW RH, et al. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokin Biopharm 1992: 20: 567-589.
8. SCHOEN RE, FRISHMAN WH, SHAMOON H. Hormonal and metabolic effects of calcium channel antagonists in man. Am J Med 1988: 84: 492-504.
9. VALENTINE H, KEOGH A, MCINTOSH N, et al. Cost containment: coadministration of diltiazem and cyclosporine after heart transplantation. J Heart Lung Transplant 1992: 11: 1-8.
10. BROCKMULLER J, NEUMAYER H-H, WAGNER K, et al. Pharmacokinetic interaction between cyclosporine and diltiazem. Eur J Clin Pharmacol 1990: 38: 237-242.
11. D'AMBROSIO A, GIACOMINI E, CAMPONESHCI B, et al. Diltiazem modulates monokine production in human mixed lymphocyte culture. Transplantation 1998: 65: 1411-1413.
12. KUNZENDORF U, WALZ G, BROCKMOELLER J, et al. Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Transplantation 1991: 52: 280-284.
13. ROTA S, RAMBALDI A, GASPARI F, et al. Methylprednisone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis. Kidney Int 1992: 42: 981-990.
14. BROMBERG JS, ALFREY EJ, BARKER CF, et al. Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 1991: 51: 385-390.
15. CHRYSOSTOMOU A, WALKER R, RUSS G, et al. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 1993: 55: 300-304.
16. SINCLAIR NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992: 147: 645-657.
17. STRATTA RU, ARMBRUST MJ, OH C, et al. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988: 45: 323-328.
18. WASSNER SJ, MALEKZADEH NH, PENNISI AJ, et al. Allograft survival in patients receiving anticonvulsant medications. Clin Nephrol 1977: 8: 293-297.
19. MOORE LW, ALLOWAY RR, ACCHIARDO SR, et al. Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole. Transplantation 1996: 61: 537-541.
20. HRICIK DE, SCHULAK JA. Metabolic effects of steroid withdrawal in adult renal transplant recipients. Kidney Int 1993: 43: S26-S29.
21. KLARE B, STROM TM, HAHN H, et al. Remarkable long-term prognosis and excellent growth in kidney transplant children under cyclosporine monotherapy. Transplant Proc 1991: XXIII.I.: 1013-1017.
22. OST L. Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients. Transplantation 1987: 44: 533-535.
23. ROCCI ML Jr, TIETZE KJ, LEE J, et al. The effect of cyclosporine on the pharmacokinetics of prednisolone in renal transplant patients. Transplantation 1988: 45: 656-660.